Home > Healthcare > Medical Devices > Therapeutic Devices > Dialyzers Market

Dialyzers Market - By Type (High-flux, Low-flux), By Material (Synthetic, Cellulose-based), By Usage (Disposable, Reusable), By End-use (In-center, Home Dialysis) – Global Forecast, 2024 – 2032

  • Report ID: GMI4684
  • Published Date: Feb 2024
  • Report Format: PDF

Dialyzers Market Size

Dialyzers Market size was valued at around USD 5.2 billion in 2023 and is expected to grow at a CAGR of 7% between 2024 and 2032. This robust market growth can be attributed to factors including the increasing prevalence of chronic kidney diseases coupled with the rising demand for home dialysis therapies.

Dialyzers Market

The primary catalyst for the growth of the market is the increasing incidence of chronic kidney diseases globally. Factors such as aging population, lifestyle-related diseases, and a higher prevalence of conditions such as diabetes and hypertension contribute to the surge in CKD cases. For instance, according to the data reported by American Kidney Fund, in 2022, around 37 million Americans were living with some kind of kidney disorder.

The aging demographic, particularly in developed regions, is prone to age-related health issues, including kidney-related complications. As the global population ages, there is a corresponding rise in the prevalence of chronic kidney diseases, necessitating the use of dialyzers for continuous renal replacement therapy.

Dialyzers are medical devices used in the process of hemodialysis to help remove waste products and excess fluids from the blood when the kidneys are no longer able to perform this function adequately. The dialyzer works by facilitating the exchange of substances between the patient's blood and a special dialysis fluid, often referred to as dialysate.

Dialyzers Market Trends

Technological advancements have led to the development of high-efficiency hemodialysis equipment and hemodiafiltration systems. These innovations enable more effective removal of waste products and toxins from the blood during dialysis, enhancing the overall therapeutic outcomes for patients.

  • Ongoing research and development efforts have resulted in innovative dialyzer designs with improved biocompatibility and enhanced dialysis performance. Novel materials and membrane technologies contribute to reducing the risk of complications and increasing the efficiency of the dialysis process.
  • For instance, in May 2020, Outset Medical a U.S.-based medical technology company launched the Tablo hemodialysis system. This system aims to simplify and improve patient convenience with advanced dialysis features. Tablo hemodialysis system is suitable for providing extended therapy for 24 hours (XT), slow low-efficiency dialysis (SLED), standard hemodialysis (HD), isolated ultrafiltration (UF only), and sequential therapy, that is HD-UF and UF-HD.
  • Moreover, the introduction of online hemodiafiltration systems represents a significant technological leap in dialysis. OL-HDF combines hemodialysis and hemodiafiltration, offering improved clearance of larger molecular weight toxins and providing superior clinical outcomes for patients undergoing dialysis, contributing to market development.

Dialyzers Market Analysis

Dialyzers Market, By Type, 2021 – 2032 (USD Billion)

Based on type, the market is categorized into high-flux dialyzers and low-flux dialyzers. The high-flux dialyzers segment accounted for the majority share and was valued at over USD 3.5 billion revenue in 2023.

  • High-flux dialyzers are designed to achieve superior solute removal efficiency during the dialysis process. Their advanced membrane technology allows for the effective clearance of a broader range of uremic toxins, including larger molecular-weight substances.
  • Additionally, the membranes used in high-flux dialyzers are characterized by enhanced biocompatibility. This feature minimizes the risk of adverse reactions and inflammatory responses during dialysis, contributing to the overall safety and tolerability of the treatment.
  • Moreover, nephrologists and healthcare providers often prefer high-flux dialyzers in clinical practice due to their demonstrated clinical benefits. The choice of these dialyzers is driven by the desire to provide the best possible care to patients undergoing dialysis for renal replacement therapy. This adaptability contributes to the widespread adoption of these systems in medical facilities.


Dialyzers Market, By Material (2023)

Based on material, the dialyzers market is segmented into synthetic, and cellulose based. The synthetic segment held the leading revenue share in 2023 and is anticipated to reach USD 4.6 billion by 2032.

  • Synthetic polymers used in dialyzer membranes, such as polyethersulfone (PES) or polysulfone (PS), can be manufactured with greater precision and efficiency compared to natural materials like cellulose. The production process for synthetic membranes is well-established, allowing for large-scale manufacturing at a relatively lower cost making it more effective than cellulose-based dialyzers.
  • In addition, dialyzers made of synthetic materials are renowned for their durability and resilience to degradation, resulting in an increased lifespan and lowering the need for replacement of dialyzers. The reduced need for frequent dialyzer replacements translates into cost savings for healthcare providers and patients. This cost-effectiveness is crucial in managing the overall financial burden associated with chronic kidney disease treatment.

Based on usage, the dialyzers market is categorized into disposable and reusable. The disposable segment accounted for around USD 2.9 billion in revenue size in 2023.

  • The use of disposable dialyzers reduces the need for the labor-intensive process of cleaning, disinfecting, and sterilizing reusable dialyzers. This results in cost savings, low maintenance requirements and reprocessing activities. Healthcare facilities may find disposable dialyzers economically advantageous due to reduced labour costs associated with their use.
  • Moreover, using disposable dialyzer reduces the risk of infection and contamination, thereby, supporting a higher standard of patient safety.
  • Furthermore, improvements in the materials used to make disposable dialyzers, such as biocompatible and effective membranes, lead to better patient outcomes and increased performance. Technological advancements in disposable dialyzer materials make them more appealing to healthcare providers seeking optimal performance in renal replacement therapy.

Based on end-use, the dialyzers market is categorized into in-center and home dialysis. The in-center segment accounted for the majority of revenue share and was valued at around USD 3.6 billion revenue in 2023.

  • The demand for dialyzers in in-center facilities is directly related to the prevalence of kidney diseases, especially chronic kidney disease (CKD). As the number of patients with kidney diseases increases, there is a corresponding rise in the demand for dialysis services and, consequently, dialyzers.
  • Healthcare policies and reimbursement mechanisms can influence the utilization of in-center dialysis services. Further, patient preferences and physician recommendations regarding treatment modalities (in-center hemodialysis) can spur the demand for dialyzers in in-center facilities.


North America Dialyzers Market, 2020 – 2032 (USD Billion)

North America dialyzers market accounted for USD 2.2 billion in revenue in 2023 and is predicted to witness substantial market growth.

  • North America has a high prevalence of Kidney-related disorders, especially in older people. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2019, more than 1 in 7 U.S. adults, were estimated to have CKD. The chance of acquiring chronic kidney disease (CKD) and requiring dialysis rises with age, thus, fueling the demand for dialyzers.
  • Furthermore, dialysis treatment for individuals with end-stage renal disease (ESRD) is primarily funded by Medicare in the U.S. Private insurance companies also provide dialysis treatment coverage in the country. Additionally, dialysis patients in Canada do not have to pay for their treatments out of pocket as the public healthcare system covers all costs associated with dialysis, including dialyzers. Such favourable reimbursement policies and funding are anticipated to propel the market growth in the region.

Dialyzers Market Share

The dialyzer industry is consolidated in nature, with various large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products with improved efficiency and cost-effectiveness is among a key market strategy for dialyzer manufacturers. Some of the leading industry players including Baxter International Inc., B. Braun Melsungen AG, Inc., Medtronic plc, Allmed Medical Care Holdings Limited, and Asahi Kasei Medical Co., Ltd, among others have a substantial presence in the market.

Dialyzers Market Companies

Some of the eminent market participants operating in the dialyzers industry include:

  • Allmed Medical Care Holdings Limited
  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • China Chengdu Wesley Biotech Co.
  • Dialifegroup
  • Farmasol
  • Fresenius SE & Co. KGaA
  • Kawasumi Laboratories Inc.
  • Medica Group
  • Medivators, Inc.
  • Medtronic, Plc.
  • Nikkiso Co., Ltd

Dialyzers Industry News:

  • In April 2023, Medtronic in partnership with DaVita launched a new joint venture called Mozarc Medical, focused on developing new kidney care technologies with a specific focus on at-home treatments. The company is committed to reshaping kidney care through meaningful and innovative kidney health technologies that improve patient outcomes. This partnership will enhance both the company's market reach and may enable an increased customer base.

Dialyzers market research report includes an in-depth coverage of the industry with estimates & forecasts in terms of revenue in USD Million from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Type

  • High-flux dialyzers
  • Low-flux dialyzers

Market, By Material

  • Synthetic
  • Cellulose-based

Market, By Usage

  • Disposable
  • Reusable

Market, By End-use

  • In-center
  • Home dialysis

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • UAE
    • Rest of Middle East and Africa


Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

Dialyzers industry was worth USD 5.2 billion in revenue in 2023 and is anticipated to expand at 7% CAGR from 2024-2032 driven by the increasing prevalence of chronic kidney diseases coupled with the rising demand for home dialysis therapies.

High-flux segment generated more than USD 3.5 billion in 2023 and is estimated to witness high demand through 2032 owing to its design to help achieve superior solute removal efficiency during the dialysis process.

North America dialyzers industry size was worth USD 2.2 billion in 2023 and is set to expand at a robust pace through 2032 attributed to the high prevalence of kidney-related disorders, especially in older people.

Some of the top dialyzer firms are Allmed Medical Care Holdings Limited, Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Baxter International Inc., China Chengdu Wesley Biotech Co., Dialifegroup, Farmasol, Fresenius SE & Co. KGaA, Kawasumi Laboratories Inc., Medica Group, Medivators, Inc., Medtronic, Plc., and Nikkiso Co., Ltd.

Dialyzers Market Scope

Buy Now

Premium Report Details

  • Base Year: 2023
  • Companies covered: 13
  • Tables & Figures: 256
  • Countries covered: 22
  • Pages: 130
 Download Free Sample